Effect of omega-3 fatty acids supplementation in polycystic ovary syndrome patients
Phase 2
- Conditions
- polycystic ovary syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT201011083664N3
- Lead Sponsor
- Vice-chancellor for research, Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 64
Inclusion Criteria
woman with polycystic ovary syndrome, 20-35 years old and BMI of 25-40. Exclusion criteria: thyroid disorders, hyperprolactinemia, Cushing syndrome, liver, kidney and cardiovascular disease, diabetes, pregnancy and lactation, smoking, use of anti obesity drugs, lipid lowering agent , glucocorticoids, anti coagulation drugs, use a lowering weight diet, have a usual sports program, receiving omega-3 supplement during 2 month ago and receiving any nutritional supplements during the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method